Skip to main content

and
  1. Article

    Open Access

    Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients

    Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of...

    Emilia L Lim, Diane L Trinh, David W Scott, Andy Chu, Martin Krzywinski in Genome Biology (2015)

  2. Article

    Open Access

    Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

    Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal DNA from 13 DLBCL cases and one FL case to i...

    Ryan D. Morin, Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya in Nature (2011)